A Negative Side Effect of COVID-19: Reduced Cancer Screenings
Photo by National Cancer Institute on Unsplash

A Negative Side Effect of COVID-19: Reduced Cancer Screenings

In her early 20's, Mackenzie Alleman lost her mother to breast cancer. Then, at 28, she herself underwent a preventative double mastectomy after learning that she carried the mutated BRCA1 gene.…

Continue Reading A Negative Side Effect of COVID-19: Reduced Cancer Screenings
Phase 1 Clinical Data on STRO-002 Shows Promise for Treating Ovarian Cancer
Sourced from Pixabay

Phase 1 Clinical Data on STRO-002 Shows Promise for Treating Ovarian Cancer

According to a press release from PR Newswire and GuruFocus, drug discovery and development company Sutro Biopharma received promising phase 1 clinical data for their drug therapy STRO-002. Their Phase…

Continue Reading Phase 1 Clinical Data on STRO-002 Shows Promise for Treating Ovarian Cancer
The Increasing Role of PARP Inhibitors for the Treatment of Ovarian Cancer
source: pixabay.com

The Increasing Role of PARP Inhibitors for the Treatment of Ovarian Cancer

Poly ADP-ribose polymerase (PARP) inhibitors have played an increasing role in the treatment of ovarian cancer. They are being very heavily studied in clinical trials, both for the treatment of…

Continue Reading The Increasing Role of PARP Inhibitors for the Treatment of Ovarian Cancer
Experimental Treatment for Ovarian Cancer Earns FDA Fast Track Designation
source: pixabay.com

Experimental Treatment for Ovarian Cancer Earns FDA Fast Track Designation

According to a story from Targeted Oncology, the US Food and Drug Administration (FDA) has granted Fast Track designation to the experimental drug OMP-305B83, also known as navicixiumab. This designation…

Continue Reading Experimental Treatment for Ovarian Cancer Earns FDA Fast Track Designation

The FDA has Extended Approval of Zejula for Ovarian Cancer Patients With and Without BRCA Mutations

GlaxoSmithKline (GSK) has just announced that Zejula, otherwise known as niraparib, has just been approved for cancer patients beyond those who have a BRCA+ mutation. The patients now included in…

Continue Reading The FDA has Extended Approval of Zejula for Ovarian Cancer Patients With and Without BRCA Mutations

FDA Amends Original Approval of Ovarian Cancer Drug Zejula, Expanding Availability

According to a publication from OncLive, the Food and Drug Administration (FDA) recently granted priority review status to a supplemental biologics license application for Zejula. Zejula (generic name niraparib) is…

Continue Reading FDA Amends Original Approval of Ovarian Cancer Drug Zejula, Expanding Availability

A Blood Test That Can Detect Seven Types of Cancer

  Health News Digest recently published an article that describes a simple blood test called DELFI, meaning DNA evaluation of fragments for early interception. Its simplicity belies the fact that it can detect…

Continue Reading A Blood Test That Can Detect Seven Types of Cancer
Potential Treatment for BRCA Mutated Pancreatic Cancer Performs Well in Trial
mohamed_hassan / Pixabay

Potential Treatment for BRCA Mutated Pancreatic Cancer Performs Well in Trial

According to a story from BioPortfolio, AstraZeneca and Merck have recently announced the results from a phase 3 clinical trial testing olaparib (marketed as LYNPARZA®) as a treatment for BRCA…

Continue Reading Potential Treatment for BRCA Mutated Pancreatic Cancer Performs Well in Trial

CRISPR Uncovers New Gene Fusion as Novel Drug Target for Brain, Ovarian and other Cancers

  CRISPR-Cas9, the genome editing tool, has caused quite a stir in the scientific community. According to a recent article in Science Daily, with results published in Nature Communications, CRISPR has…

Continue Reading CRISPR Uncovers New Gene Fusion as Novel Drug Target for Brain, Ovarian and other Cancers
Trial Data Reveals Improved Quality of Life for Ovarian Cancer Patients Taking Rucaparib
stevepb / Pixabay

Trial Data Reveals Improved Quality of Life for Ovarian Cancer Patients Taking Rucaparib

According to a story from BioPortfolio, the biopharmaceutical company Clovis Oncology, Inc. recently released data from a phase 3 clinical trial of patients with recurrent ovarian cancer taking the company's…

Continue Reading Trial Data Reveals Improved Quality of Life for Ovarian Cancer Patients Taking Rucaparib
Could This Investigational Drug be a New Treatment Option for Acute Myeloid Leukemia?
qimono / Pixabay

Could This Investigational Drug be a New Treatment Option for Acute Myeloid Leukemia?

According to a story from globenewswire.com, the biopharmaceutical company Innovation Pharmaceuticals recently released a report in which recent studies and pre-clinical research has suggested that the company's experimental drug Kevetrin…

Continue Reading Could This Investigational Drug be a New Treatment Option for Acute Myeloid Leukemia?
Woman Receives False Positive Test Result for Cancer Causing BRCA Mutation
mcmurryjulie / Pixabay

Woman Receives False Positive Test Result for Cancer Causing BRCA Mutation

According to a story from kshb.com, Maureen Boesen was already prepared for the worst when she first took a DNA test in order to determine if she carried a BRCA…

Continue Reading Woman Receives False Positive Test Result for Cancer Causing BRCA Mutation
Actress Kathy Bates Discusses Being Diagnosed With Ovarian Cancer and Breast Cancer…and Surviving
laurixnh / Pixabay

Actress Kathy Bates Discusses Being Diagnosed With Ovarian Cancer and Breast Cancer…and Surviving

According to a story from yahoo.com, actress Kathy Bates realized when she was fairly young that she was at an increased risk for breast cancer. This was because both her…

Continue Reading Actress Kathy Bates Discusses Being Diagnosed With Ovarian Cancer and Breast Cancer…and Surviving
Close Menu